Change of Adviser

14th Jan 2008 07:01

Allergy Therapeutics PLC14 January 2008 14 January 2008 Allergy Therapeutics plc ("Allergy Therapeutics" or "the Company") Change of Adviser Allergy Therapeutics is pleased to announce the appointment, with immediateeffect, of Nomura Code Securities Limited as Nominated Adviser to the Company. For further information: Allergy Therapeutics +44 (0) 1903 845 820Keith Carter, Chief Executive Nomura Code Securities +44 (0) 207 776 1204Juliet Thompson Financial Dynamics +44 (0) 207 831 3113Ben Brewerton This information is provided by RNS The company news service from the London Stock Exchange

---

Related Shares:

Allergy Thera.